Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Provision or distribution of growth hormone for "Antiaging"

Article Abstract:

The distribution and marketing of human growth hormone (HGH or GH) through Web sites and antiaging clinics has grown into a multimillion-dollar antiaging industry. A nonsystematic viewing of numerous Web sites revealed that the cost of pills and sprays allegedly containing GH is substantial, with both costing the consumer as much as $200 to $300 for what marketers indicate as a month's supply.

Author: Olshansky, S. Jay, Perls, Thomas T., Reisman, Neal R.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
Aging, Control, Somatotropin, Aging (Biology)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The "duty to warn" a patient's family members about hereditary disease risks

Article Abstract:

The article examines the legal and ethical issues surrounding genetic testing and the physician-patient privilege. The authors support the roles of medical personnel in encouraging but not coercing patients to share genetic information with their families.

Author: Offit, Kenneth, Groeger, Elizabeth, Turner, Sam, Wadsworth, Eve A., Weiser, Mary A.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2004
Interpretation and construction, Genetic screening, Genetic testing, Confidential communications, Failure to warn (Law), Physician-patient privilege

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Medical students' exposure to and attitudes about drug company interactions: A national survey

Article Abstract:

Third-year medical student's exposure to and attitudes about drug company interactions are measured. Student experiences and attitudes suggest that as a group they are at risk unrecognized influence by marketing efforts.

Author: Woodard, John L., Sierles, Frederick S., Cleary, Lynn M., McCurdy, Frederick A., Lynn, D. Joanne, Morgenstern, Bruce Z., Brodkey, Amy C., Frank, Julia, Mintz, Matthew, Chao, Jason, Shore, William
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
Financial management, Finance, Medical students, Education, Surveys, Endorsements, Company financing, Continuing medical education, Educational aspects

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Laws, regulations and rules, Pharmaceutical industry, Marketing, Government regulation, Ethical aspects, Company marketing practices
Similar abstracts:
  • Abstracts: Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. Zoledronic acid and clinical fractures and mortality after hip fracture
  • Abstracts: Normalization of hemoglobin level in patients with chronic kidney disease and anemia. The medical management of depression
  • Abstracts: A district nursing renaissance. New push for PBC. Driving down infection
  • Abstracts: Sequence-specific potent induction of IFN-alpha by short interfering RNA in the plasmacytoid dendritic cells through TLR7
  • Abstracts: Lack of interferon response in animals to naked siRNAs. Is it a DC, is it an NK? No, it's an IKDC. Sensing the danger in RNA
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.